• Skip to main content
  • Skip to secondary menu

3V.org

Venture Capital Trends: Follow the Money

  • Market Reports
  • Sponsored Post
  • Contact
    • About

Cancer

Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer

April 7, 2020 By 3v.org Leave a Comment

Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease causing proteins, today announced the closing of a USD $7.5m Series A round, led by Advent Life Sciences. Seed round funders the Scottish Investment Bank, with backing from the Scottish … [Read more...] about Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer

Copyright © 2018 3V.org